ATRC - エイトリキュア （AtriCure Inc.）ATRCのニュース
Needham & Company maintains AtriCure at Buy with a price target of $60.00 2023/05/03 15:57:37 Investing.com
https://www.investing.com/news/pro/atricure-receives-investment-bank-analyst-rating-update-3071617
AtriCure, Inc. (ATRC) Q1 2023 Earnings Call Transcript 2023/05/03 01:40:06 Seeking Alpha
AtriCure, Inc. (NASDAQ:NASDAQ:ATRC) Q1 2023 Earnings Conference Call May 2, 2023 4:30 PM ETCompany ParticipantsMarissa Bych – Vice President-Gilmartin GroupMike Carrel – President and Chief…
AtriCure Non-GAAP EPS of -$0.23 beats by $0.12, revenue of $93.5M beats by $5.97M 2023/05/02 20:17:26 Seeking Alpha
AtriCure press release (ATRC): Q1 Non-GAAP EPS of -$0.23 beats by $0.12.Revenue of $93.5M (+25.4% Y/Y) beats by $5.97M.2023 Financial GuidanceFull year 2023 revenue is projected to…
AtriCure (ATRC) Presents At Oppenheimer 33rd Annual Health Conference - Slideshow 2023/03/21 15:06:46 Seeking Alpha
The following slide deck was published by AtriCure, Inc.
AtriCure, Inc. (ATRC) Q4 2022 Earnings Call Transcript 2023/02/22 03:47:06 Seeking Alpha
AtriCure, Inc. (NASDAQ:NASDAQ:ATRC) Q4 2022 Earnings Conference Call February 21, 2023 4:30 PM ETCompany ParticipantsMarissa Bych - Gilmartin Group, Investor RelationsMichael Carrel -…
AtriCure, Inc. (ATRC) Q4 2022 Earnings Call Transcript 2023/02/22 03:47:06 Seeking Alpha
AtriCure, Inc. (NASDAQ:NASDAQ:ATRC) Q4 2022 Earnings Conference Call February 21, 2023 4:30 PM ETCompany ParticipantsMarissa Bych - Gilmartin Group, Investor RelationsMichael Carrel -…
AtriCure: Q4 Earnings Snapshot 2023/02/21 21:13:33 WTOP
MASON, Ohio (AP) — MASON, Ohio (AP) — AtriCure Inc. (ATRC) on Tuesday reported a loss of $4.2 million in…
AtriCure GAAP EPS of -$0.09 beats by $0.09, revenue of $88M beats by $0.1M 2023/02/21 21:04:24 Seeking Alpha
AtriCure press release (ATRC): Q4 GAAP EPS of -$0.09 beats by $0.09.Revenue of $88M (+20.2% Y/Y) beats by $0.1M.Adjusted EBITDA was positive for the fourth quarter 2022 at $6.0…
AtriCure Reports Fourth Quarter 2022 and Full Year 2022 Financial Results 2023/02/21 21:00:00 Wallstreet:Online
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced fourth quarter 2022 and full year 2022 financial results. “We delivered another outstanding year of growth in 2022, as we expanded adoption across our broad portfolio of solutions. I
Earnings Outlook For AtriCure 2023/02/20 15:00:56 Benzinga
AtriCure (NASDAQ: ATRC ) is set to give its latest quarterly earnings report on Tuesday, 2023-02-21. Here''s what investors need to know before the announcement. Analysts estimate that AtriCure will report an earnings per share (EPS) of $-0.18. AtriCure bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next … Full story available on Benzinga.com
AtriCure (ATRC) Investor Presentation - Slideshow 2022/08/20 14:55:50 Seeking Alpha
The following slide deck was published by AtriCure, Inc.
AtriCure, Inc. (ATRC) CEO Mike Carrel on Q2 2022 Results - Earnings Call Transcript 2022/08/03 05:08:05 Seeking Alpha
AtriCure, Inc. (NASDAQ:NASDAQ:ATRC) Q2 2022 Earnings Conference Call August 2, 2022 16:30 ET Company Participants Marissa Bych - Investor Relations Mike Carrel - President and Chief…
AtriCure: Q2 Earnings Insights 2022/08/02 21:21:47 Benzinga
AtriCure (NASDAQ: ATRC ) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:01 PM. Here''s what investors need to know about the announcement. Earnings AtriCure missed estimated earnings by 10.34%, reporting an EPS of $-0.32 versus an estimate of $-0.29. Revenue was up $13.15 million from the same period last … Full story available on Benzinga.com
AtriCure GAAP EPS of -$0.32 misses by $0.03, revenue of $84.53M beats by $4.86M 2022/08/02 20:02:05 Seeking Alpha
AtriCure press release (ATRC): Q2 GAAP EPS of -$0.32 misses by $0.03.Revenue of $84.53M (+18.4% Y/Y) beats by $4.86M.
AtriCure Reports Second Quarter 2022 Financial Results 2022/08/02 20:00:00 Wallstreet:Online
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced second quarter 2022 financial results. “We delivered a remarkable second quarter as we continue changing the standard of care for millions of patients globally,” said Michael Carrel,